ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Bruker (BRKR)
Bruker stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · NASDAQ
$59.86▲ +2.80%
Prices as of Oct 26, 2026 · USD
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Bruker in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Bruker
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Bruker a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $54.86 and $64.80; in 9 out of 10, between $47.33 and $75.11. Estimated annual volatility is 50%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $9.9B
- Dividend yield
- 0.33%
- 52-week high
- $66.98
- 52-week low
- $32.37
- Revenue (12 months)
- $3.5B
- Revenue growth (YoY)
- +2.1%
- Earnings growth (YoY)
- -119.7%
- Gross margin
- 45.9%
- Operating margin
- 6.9%
- Net margin
- -0.2%
- Return on equity
- -3.0%
- Free cash flow (12 months)
- $180M
- Beta
- 1.26
What this means
ATLAS does not publish a fair value for BRKR right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks BRKR has traded between $32.37 and $66.98. Today it is 10.6% below that high and 85% above its low.
On the business: revenue grew 2.1% year over year; net margin is 0.2%.
Its beta is 1.26: it tends to move more than the market, both up and down.
About the company
Bruker Corp. is a scientific instruments and analytical solutions company that provides technologies for life science, materials research, and diagnostic applications.
Want to see everything about Bruker?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Bruker do?
Bruker Corp. is a scientific instruments and analytical solutions company that provides technologies for life science, materials research, and diagnostic applications.
What is the chance BRKR goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, BRKR ends the month between $54.86 and $64.80.
How big is Bruker and what is its P/E ratio?
Bruker's market capitalization is $9.9B. We do not show a P/E because it has no positive earnings to base one on.
Does Bruker pay a dividend?
Yes. BRKR's current dividend yield is 0.33% at today's price ($59.86).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer